Health Professional Radio - Podcast

Dr. Marcia Brose, Associate Professor at the University of Pennsylvania School of Medicine discusses the role of cancer genomic testing and Neurotrophic Tropomyosin Receptor Kinase (NTRK) gene fusions. NTRK gene fusions can cause cancer cells to multiply, form tumors, and are more common in certain thyroid and colon cancer subtypes. Bayer and Neogenomics Inc. launched the Test4TRK™ program to offer genomic cancer testing for NTRK gene fusions at no cost for patients who meet certain criteria.

Dr. Sean Boynes, DMD, MS, Vice President of Health Improvement at DentaQuest discusses teledentistry an unexpected outcome of the COVID-19 pandemic.

Eleusis is a clinical-stage life science company that has two lines of business: a traditional drug development arm called Eleusis Therapeutics, and a care delivery platform called Eleusis Health Solutions. Here to discuss the company and the potential and power of psychedelic medicine in treating chronic inflammatory disease, mental health, and Alzheimer's is CEO, founder, and chairman, Shlomi Raz.

Founder and CEO of Miiskin Jon Friis discusses the partnership between the Skin Cancer Foundation and Miiskin for Skin Cancer Awareness Month to remind people to perform self-skin exams. Miiskin is a digital health platform supported by the dermatological community as a tool to help track skin changes.

Bonnie J. Addario, Co-Founder, Board Chair, GO2 Foundation for Lung Cancer discusses the foundation along with other patient advocacy group's support of Guardant Health's "Clear Your View" campaign to bring awareness around comprehensive genomic testing for patients with metastatic non-small cell lung cancer (NSCLC) before first-line treatment.

Dr. Benjamin Levy, Division Head Of Gastroenterology at Mount Sinai Hospital in Chicago, discusses the impact the pandemic has had on colorectal cancer screening and diagnostics, the expected backlog when offices open back up, and the role at-home tests (like Cologuard®) can play to filter the right people into diagnostic screening.

Radiologist, Dr. Doug Beall, MD, from the Oklahoma Spine Hospital, discusses ways to educate patients about PMO, the connection to fractures, and current treatment options.

Dr. Suzanne Steinbaum, a cardiologist, discusses the controversy between women and statins, best practices on how women with a full plate of responsibilities can still prioritize their health, and how she maintains open relationships with her patients in this new virtual landscape.

Dr. Linda Marbán, President, CEO and Director of Capricor Therapeutics discusses new data reporting 100 percent survival in critical COVID-19 patients that were treated with her team's off-the-shelf, cardiac cell therapy CAP-1002. These patients were part of six compassionate care cases treated at Cedars-Sinai Medical Center in Los Angeles, and following a review of the data, the FDA approved the company’s expanded access protocol to treat additional COVID-19 patients with this novel new therapeutic

Kate Drake, Head of Product Marketing with Corindus, a Siemens Healthineers Company, discusses the CorPath® GRX robotic system that was developed to make complex heart and brain procedures safer for patients and physicians by limiting radiation exposure and making physician movements more precise, but it can also be operated remotely. Currently, physicians will control the robot while seated across the room, but a cardiologist in India successfully performed five heart procedures in 2018 while controlling the robot over a hardwired internet connection from 20 miles away. Robotic-assisted procedures are turning out to be very beneficial during the pandemic.

With more patients turning to home exercise there has been a rise in foot injuries. Dr. Kyle Kinmon, a leading podiatrist in South Florida discusses how patients can seek specialized treatment if they are uncomfortable going to the doctor's office, what people experiencing foot/ankle issues should do and when to know if they have to be seen by a specialist, and what to do to prevent foot complications

Dr. Mark Erlander, CEO of Cardiff Oncology discusses their lead drug candidate Onvansertib and the three active clinical trials in colorectal cancer, acute myeloid leukemia, and prostate cancer. Onvansertib specifically targets and inhibits a downstream enzyme, PLK1, effectively stopping cancer cell division.

Dr. Becky Nagy, Vice President of Medical Affairs at Guardant Health talks about the "Clear Your View" campaign that Guardant Health and three advocacy groups, including Go2 Foundation for Lung Cancer, LUNGevity Foundation, and ALK Positive, have come together to underscore the importance of comprehensive genomic testing. The campaign encourages oncologists to "stop, test, and wait" for the complete genomic profile for new patients with advanced metastatic non-small cell lung cancer (NSCLC) before starting first-line treatment.

Returning guest Dr. Paul Limburg, a gastroenterology consultant at the Mayo Clinic, and CMO for screening at Exact Sciences discusses new data from the Colorectal Cancer and Adenoma Incidence and Mortality model (CRC-AIM) shared as several e-presentations published by Digestive Disease Week (DDW) 2020 that shows the value of Cologuard® (mt-sDNA) as an effective colorectal cancer screening test over fecal immunochemical testing (FIT). The research also highlights the need for improved access to colonoscopy following a positive Cologuard® test or FIT.

Heart surgeon turned medical device entrepreneur, Dr. Lishan Aklog, CEO of PAVmed, Inc., discusses EsoGuard, a non-evasive esophageal DNA test and EsoCheck, a non-invasive cell collection device for the detection of Barrett's Esophagus, a little-known precursor to esophageal cancer

Dr. Becky Nagy, Vice President of Medical Affairs at Guardant Health discusses the phase l/ll study led by Memorial Sloan Kettering Cancer Center and published in "Nature Cancer" that showed Guardant360® liquid biopsy test identifies predictors of response to PIK3CA inhibitors in women with HR+ Metastatic Breast Cancer.

Dr. Lisa C. Richardson, MD, Director of the Centers for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC), discusses what cancer patients and their caregivers need to know to stay well while staying at home during the COVID-19 crisis and what to do should anyone with cancer or caring for someone with cancer contract COVID-19.

Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences® discusses MI Exome™ a next-generation sequencing-based assay analyzing the whole exome of 22,000 DNA genes. This new assay will be offered as part of the Caris Molecular Intelligence® suite of comprehensive profiling services that are designed to detect and characterize the molecular features of cancer to guide more precise individualized treatment decisions for patients.

Dr. Dan Carlin, founder, and CEO of WorldClinic discusses the services provided by WorldClinic, how they are helping save lives during COVID-19, and how he remotely saved a patient whose heart had stopped using his iPhone.

Dr. Eunice Wang, M.D. at Roswell Park Comprehensive Cancer Center, talks about acute myeloid leukemia (AML) an aggressive form of blood cancer that presents with many different subtypes. She also discusses why genetic testing for mutations is critical in making treatment decisions amid COVID-19 and beyond.